Intravenous mirtazapine in the treatment of depressed inpatients
2002
Abstract Mirtazapine is a novel antidepressant with a noradrenergic and specific serotonergic mode of action. So far, mirtazapine has been administered orally. This naturalistic study evaluates the antidepressant efficacy, safety, and tolerability of mirtazapine 15 mg/day administered intravenously to 27 inpatients with moderate to severe major depression. Compared with baseline, we found a significant decrease of the Hamilton Depressive Rating Scale (HDRS) total score ( P
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
32
References
12
Citations
NaN
KQI